WILSON GLYNN has filed 8 insider transactions across 3 companies since January 2023.
Most recent transaction: a disposition of 1500000 shares of Caring Brands, Inc. ($CABR) on March 27, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Caring Brands, Inc. | $CABR | WILSON GLYNN | Chief Executive Officer | D | Common Stock | 1500000 | $0.50 | 672,592.0000 | 13,736,925 | 69.04% | 10.92% |
| Dec. 11, 2025 | Caring Brands, Inc. | $CABR | WILSON GLYNN | Chief Executive Officer | A | Common Stock | 126720 | $0.00 | 2,126,720.0000 | 13,736,925 | 5.62% | 0.92% |
| Dec. 11, 2025 | Caring Brands, Inc. | $CABR | WILSON GLYNN | Chief Executive Officer | A | Common Stock | 45872 | $0.00 | 2,172,592.0000 | 13,736,925 | 2.07% | 0.33% |
| Jan. 23, 2025 | Cadrenal Therapeutics, Inc. | $CVKD | WILSON GLYNN | Director | A | Stock Options | 20000 | $0.00 | 20,000.0000 | 1,219,550 | 9999.99% | 1.64% |
| March 1, 2024 | BONK, INC. | $BNKK | WILSON GLYNN | Former CSO, Chairman | D | Stock Options | 1900000 | $0.00 | 187,344.0000 | 0 | 0.00% | 0.00% |
| Jan. 18, 2024 | Cadrenal Therapeutics, Inc. | $CVKD | WILSON GLYNN | Director | A | Stock Options | 70000 | $0.00 | 70,000.0000 | 899,465 | 9999.99% | 7.78% |
| Jan. 24, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | WILSON GLYNN | Director | C | Convertible Promissory Note | 50000 | $0.00 | 0.0000 | 7,890,507 | 100.00% | 0.63% |
| Jan. 24, 2023 | Cadrenal Therapeutics, Inc. | $CVKD | WILSON GLYNN | Director | C | Common Stock | 50000 | $0.00 | 50,000.0000 | 7,890,507 | 9999.99% | 0.63% |